Oct 2026· ANPAbstract_CBN26· pp. S0988-S0988· 0 citations
TL;DR
The findings support the conceptualization of late-life depression as a brain network dysfunction in which vascular, inflammatory, and metabolic factors converge and suggest that geriatric depression may represent both a risk factor and a prodromal stage of broader cognitive deterioration.
Abstract
Background: Late-life depression is highly prevalent in older adults and has increasingly been associated with mild cognitive impairment, a condition considered an intermediate stage between normal aging and dementia. The coexistence of depressive symptoms and cognitive decline suggests shared pathophysiological mechanisms, including vascular dysfunction, chronic inflammation, metabolic disturbances, and mitochondrial impairment. Identifying early clinical markers is therefore essential to recognize individuals at higher risk of cognitive decline and to support preventive and therapeutic strategies. Objective: Identify early clinical markers associating late-life depression with mild cognitive impairment. Methods: This study is an integrative review of the current literature conducted through a PubMed database. Articles published in the last five years, written in English, and freely available in full text were included. The search strategy used the following descriptors and Boolean operators: (“Late-Life Depression” OR Depression OR Depressive Disorder)AND (“Mild Cognitive Impairment” OR Cognitive Decline)AND (Clinical Markers OR Early Markers)AND (Aged OR Elderly). A total of 447 were studies identified. From these, 100 best-match titles/abstracts screened. 18 articles were selected for full-text reading. Finally, 5 articles were selected for Inclusion in the review. Results: The reviewed studies identified potential clinical markers linking late-life depression and Mild Cognitive Impairment. Alterations in blood mitochondrial markers were observed in older adults with mild cognitive impairment and a history of major depressive disorder, suggesting shared biological mechanisms. Nutritional and energetic factors were significantly associated with cognitive decline and depressive symptoms, possibly reflecting neurogenesis-related vulnerability. Additionally, altered adiponectin levels and inflammatory markers were reported in elderly diabetic patients with both mild cognitive impairment and depressive symptoms. The findings support the conceptualization of late-life depression as a brain network dysfunction in which vascular, inflammatory, and metabolic factors converge. Longitudinal associations between depression, cerebrovascular disease, and cognitive decline suggest that geriatric depression may represent both a risk factor and a prodromal stage of broader cognitive deterioration. Interactions among inflammation, adipokines, and mitochondrial dysfunction may contribute to accelerated brain aging. Conclusion: The findings support the conceptualization of late-life depression as a brain network dysfunction in which vascular, inflammatory, and metabolic factors converge. Longitudinal associations between depression, cerebrovascular disease, and cognitive decline suggest that geriatric depression may represent both a risk factor and a prodromal stage of broader cognitive deterioration. Interactions among inflammation, adipokines, and mitochondrial dysfunction may contribute to accelerated brain aging.
Objective: This review examined whether neuropsychological patterns in older adults with late-life depression distinguish cognitive impairment related to depression from early dementia. Method/Data Selection: Studies were selected from peer-reviewed sources identified via multiple databases (e.g., PubMed, PsycINFO, A...
Ihsane Benkhadra, Melodie L. Abinader, Charles J. Golden· Archives of Clinical Neurops...· 0 citations
Background: Cognitive decline is a major health concern in older adults and results from a complex interaction between neurodegenerative, vascular, metabolic and inflammatory processes. Cardiovascular and metabolic risk factors may contribute to cognitive impairment through mechanisms including endothelial dysfunction,...
Diana-Gabriela Constantinescu, A. Ilie, Ramona Ștefăniu et al.· Medical Science· 0 citations
Mild cognitive impairment (MCI) is a prevalent syndrome affecting approximately 10-15% of the global population. In the Russian Federation, the estimated number of individuals with MCI may reach 5 million, with continued growth projected. Subjective cognitive deficits are linked to an increased risk of dementia, althou...
E. Vasenina· Zhurnal Nevrologii i Psikhia...· 0 citations
Background: Frailty is a geriatric syndrome characterized by reduced physiological reserve and increased vulnerability to adverse health outcomes, including disability, hospitalization and mortality. Emerging evidence suggests that frailty is also associated with cognitive decline and may contribute to dementia progres...
Guilherme Coelho Carvalho, João Victor de Matos Caetano, João Pedro de Oliveira Gouveia Marcotti et al.· ANPAbstract_CBN26· 0 citations
Abstract Introduction Anxiety is among the earliest and most common neuropsychiatric symptoms in cognitive impairment. Emerging evidence suggests that anxiety may elevate the risk of cognitive decline in mild cognitive impairment (MCI). This systematic review and meta-analysis was performed to quantitatively synthesize...
D. Fresnais, Brynjar Fure· Dementia and Geriatric Cogni...· 0 citations
Population aging has been accompanied by an increase in cognitive impairment and dementia, affecting autonomy, quality of life, and health systems. Although biological factors contribute to cognitive decline, many cases are associated with modifiable factors and social conditions. This study aimed to analyze modifiable...
Catarina Fontana Gomes, Bruna da Silva Basilio, João Victor Fonseca de Castro Jordão et al.· Revista Ibero-Americana de H...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.